Skip to main content
. 2018 Oct 8;34(11):497–506. doi: 10.1007/s40267-018-0560-9

Fig. 1.

Fig. 1

Simplified pathophysiology of X-linked hypophosphatemia (lighter colored boxes) and mechanism of action of burosumab in its treatment (darker colored boxes) [3, 5]